Tirzepatide Archives

Tirzepatide (Mounjaro) for Diabetes and Weight Loss

Tirzepatide is a dual GLP-1 and GIP analog that has got FDA approval for the treatment of patients with Type 2 Diabetes Mellitus. It has been associated with marked weight loss of approximately 22% which is even greater than Wegovy, an FDA-approved weight loss drug, however, Tirzepatide’s FDA approval as a weight loss drug is … Read more

Tirzepatide Side effects and How to Manage Them

by Ahmed

Tirzepatide Side effects may range from mild gastrointestinal side effects to serious life-threatening pancreatitis and kidney failure. Like the GLP-1 agonists, Semaglutide, Liraglutide, Dulaglutide, etc, it primarily acts in the gastrointestinal tract. Hence, most of the GI side effects are related to the gastrointestinal tract. What is Tirzepatide? It is the first of its class … Read more